Table 2.
Clinicopathological Analysis of tRF5-23-GlyTCC-2
| Parameter | No. of Patients | tRF5-23-GlyTCC-2 | p value | ||
|---|---|---|---|---|---|
| High (n=61) | Low (n=61) | ||||
| Sex | Male | 63 | 29 | 34 | 0.365 |
| Female | 59 | 32 | 27 | ||
| Age (year) | >60 | 82 | 44 | 38 | 0.247 |
| ≤60 | 40 | 17 | 23 | ||
| Tumor size | >5 | 22 | 9 | 13 | 0.346 |
| ≤5 | 100 | 52 | 48 | ||
| Differentiation grade | Well-moderate | 89 | 53 | 36 | 0.001 |
| Poor | 33 | 8 | 25 | ||
| T stage | T1-T2 | 49 | 32 | 17 | 0.006 |
| T3-T4 | 73 | 29 | 44 | ||
| Lymph node status | Positive | 66 | 26 | 40 | 0.011 |
| Negative | 56 | 35 | 21 | ||
| TNM stage | I–II | 53 | 34 | 19 | 0.006 |
| III–IV | 69 | 27 | 42 | ||
| Nerve/vascular-invasion | Positive | 53 | 20 | 33 | 0.018 |
| Negative | 69 | 41 | 28 | ||
| C-erbB-2 | Positive | 38 | 16 | 22 | 0.241 |
| Negative | 84 | 45 | 39 | ||
Notes: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
Abbreviation: TNM, tumor node metastasis.